160 Health International Limited filed its monthly return for the period ended 31 March 2026, indicating no changes in either authorised or issued share capital.

The authorised share capital remains at 25.00 billion ordinary shares with a par value of USD 0.000002, representing USD 50,000 in registered capital.

Issued share capital was unchanged at 336.45 million ordinary shares, and the company continued to hold zero treasury shares. Management confirmed compliance with the Hong Kong Stock Exchange’s minimum 25 percent public-float requirement.

Under the Pre-IPO Share Option Scheme, 31.18 million options were outstanding at month-end. These options cover up to 14.49 million new shares and 16.70 million existing shares; no options were exercised during March, resulting in no dilution.

The filing reported no warrants, convertible securities, share repurchases, or other equity movements during the month.